These Scientists Are Giving Themselves D.I.Y. Coronavirus Vaccines
Impatient for a coronavirus vaccine, dozens of scientists around the world are giving themselves - and sometimes, friends and family - their own unproven versions.
news
Send us a link
Impatient for a coronavirus vaccine, dozens of scientists around the world are giving themselves - and sometimes, friends and family - their own unproven versions.
Inequities and other social realities must be factored into diagnoses and tracing of COVID-19.
Lecturers say cases may soar as students move in, but ministers insist institutions are prepared.
Scientists worldwide are working against the clock to find a viable coronavirus vaccine - but are corners being cut for the sake of political gain and profit?
Author affiliations, and the ability to link them to publications and other scholarly outputs, are vital for numerous stakeholders across the research landscape. With the launch of the Research Organization Registry (ROR) in 2019 (which Crossref has helped to develop), the landscape is changing. ROR IDs are an opportunity to make affiliation details easier for publishers to use and easier for those who rely on this data.
Most detailed report yet about the impact of giant satellite clusters says damage to observations is unavoidable.
The ETH Board, swissuniversities, the Swiss National Science Foundation, Innosuisse – the Swiss Innovation Agency, and the Swiss Academies of Arts and Sciences reject the Limitation Initiative. They organised a joint press call in order to state their views on the Limitation Initiative and affirm the importance of research cooperation with Europe.
Comprehensive study suggests vaccine may not work as well for overweight people.
Tear gas from the near-nightly sieges in Portland may be trickling into the Willamette River, officials fear.
Saliva could be the key to a faster, cheaper, safer test.
As the world wearies of trying to suppress the SARS-CoV-2 virus, many of us are wondering what the future will look like as we try to learn to live with it.
A new star has been born on the academic Nordic journal scene: the Journal of Digital Social Research, launched last year. We talked to the editor-in-chief Simon Lindgren from Umeå University.
US President Donald Trump reportedly is considering skipping regulatory steps to get out a vaccine.
When a massive wildfire swept through California's oldest state park last week it was feared many trees in a grove of old-growth redwoods, some of them 2,000 years old...
A man in Hong Kong was found to be reinfected with COVID-19, but what that means for vaccines and immunity is unclear
A new study shows the Biogen conference held at Boston's Marriott Long Wharf hotel in February played a far greater role in spreading the coronavirus than previously thought.
Businesses and entrepreneurs are racing to deploy blockchain technology against all manner of problems, and perceived opportunities.
Authors with a published eLife paper can now enrich their work with embedded code blocks and computed outputs to make their results more transparent, interactive and reproducible.
"We don't … understand the extent of how this could impact us legally; we're just scared because we know it could," one student says
Women's journal submission rates fell as their caring responsibilities jumped due to COVID-19. Without meaningful interventions, the trend is likely to continue.
A German university is offering “idleness grants” to applicants who are seriously committed to doing sweet nothing.This indolence project is a serious look at societal values of success versus sustainability, says Hamburg arts college.
China’s science ministry is set to introduce its most comprehensive rules so far for dealing with research misconduct. The measures, which come into effect next month, outline what constitute violations and appropriate punishments. But critics say that enforcement will continue to be a problem.
The Trump administration this week blocked the Food and Drug Administration from regulating a broad swath of laboratory tests, including for the coronavirus, in a move strongly opposed by the agency. The new policy stunned many health experts and laboratories because of its timing, several months into a pandemic.Some public health experts worry defective tests could end up on the market, but others cheer the change, saying it is long overdue.
In an open letter to the European Commission and the European Research Council, the President of CESAER emphasises the full support for open access to scientific publications and the implementation of Plan S in Horizon Europe
Arseniy Neskhodimov named overall winner of photography prize for his series Prozac.
We want to hear how researchers and students are managing the start of term.